Hyperliquid Submits Amicus Brief Supporting Industry Innovation In U.S. Futures Trading
Hyperliquid and the Healthy Perps Coalition (HPC) filed an amicus brief supporting the CFTC's approval of perpetual futures contracts. The brief argues CME Group's lawsuit lacks standing and stifles innovation. HPC claims the CFTC's approval expanded the market, benefiting all exchanges. If CME succeeds, future innovations may face legal challenges, potentially slowing market development.
How this was made

The 30-second read
Why it matters
The amicus brief argues CME lacks standing and that the CFTC's actions expand market opportunities.
Market read
Legal outcome could influence the regulatory landscape for crypto futures and affect CME's litigation exposure.
What to watch
Potential pushback from traditional market participants resistant to crypto integration.
Background
CME filed a lawsuit against the CFTC after the regulator approved Bitcoin perpetual futures on a regulated exchange.
Ticker impact
CME Group's lawsuit against the CFTC may be affected by the amicus brief filed by Hyperliquid and the Healthy Perps Coalition.
Modest upside if the brief leads to dismissal of CME's suit.
The brief challenges CME's standing; if successful, it may lower legal expenses and improve market perception.
Market effects
May encourage other exchanges to pursue regulated crypto futures.
U.S. futures market could see increased innovation and competition.
Sets precedent for regulatory treatment of crypto derivatives worldwide.
Counterpoint
CME may still pursue other legal avenues, limiting the brief's effect.
Key entities
- platformHyperliquid
Crypto trading platform supporting the amicus brief.
- companyCME Group
Issuer of the lawsuit against the CFTC.
- regulatorCFTC
U.S. Commodity Futures Trading Commission.



